SCHEMBL4346893

SCHEMBL4346893

O=C(Nc1cc(Cl)cc(Cl)c1)N(S)c1cc(Cl)cc(Cl)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.41
TBXAS1 P24557 1/20 0.41
MAPK1 P28482 1/20 0.41
PTGS2 P35354 1/20 0.41
MAPK14 Q16539 1/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
ACLY P53396 1/20 0.41
STK39 Q9UEW8 5/20 0.40
P2RY1 P47900 1/20 0.40
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353445 0.88 TSHR (0.47) PTGS1TBXAS1MAPK1PTGS2MAPK14
SCHEMBL4346853 0.87 STK39 (0.51) PTGS1TBXAS1MAPK1PTGS2MAPK14
SCHEMBL4354035 0.84 MEN1 (0.42) STK39P2RY1ALDH1A1MEN1MAPT
SCHEMBL4342472 0.83 P2RY1 (0.41) PTGS1TBXAS1MAPK1PTGS2MAPK14
SCHEMBL4353170 0.82 ALDH1A1 (0.36) P2RY1ALDH1A1MEN1MAPTRAB9A
SCHEMBL4354221 0.82 P2RX1 (0.46) PTGS1TBXAS1MAPK1PTGS2MAPK14
SCHEMBL4350861 0.81 ALDH1A1 (0.38) P2RY1ALDH1A1MEN1MAPTRAB9A
SCHEMBL4341696 0.81 P2RX1 (0.54) P2RY1TSHRMEN1MAPTRAB9A
SCHEMBL4357681 0.79 KMT2A (0.36) ACLYP2RY1ALDH1A1RECQLMEN1
SCHEMBL4349759 0.77 NPSR1 (0.43) P2RY1ALDH1A1TSHRMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 PTGS1 2026/4885TBXAS1 2592/4885MAPK1 2517/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 PTGS1 1789/4885TBXAS1 2599/4885MAPK1 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.